Limerston Capital Acquires Concept Life Sciences from Spectris plc

Limerston Capital LLP has acquired Concept Life Sciences, a UK-based contract research organisation (CRO), in a carve-out from Spectris plc through its new fund Limerston Capital Partners II. The deal provides Concept Life Sciences with independent ownership, new leadership under CEO Dr Ben Cliff and additional investment to support growth across its drug discovery, development and API manufacturing services. Limerston intends to use the business as a platform for further buy-and-build and operational expansion in the life sciences sector.